Article
Rationale for maintenance of the M184v resistance mutation in human immunodeficiency virus type 1 reverse transcriptase in treatment experienced patients.
The new microbiologica - 1 Apr 2004
Turner D, Brenner B G, Routy J P, Petrella M, Wainberg M A
Abstract excerpt
The M184V substitution in HIV-1 RT develops rapidly following initiation of therapy with 3TC and confers high-level phenotypic resistance to this drug both in vitro and in vivo. Interestingly, the presence of M184V is also associated with alteration of several mechanisms relating to RT function that include decreased RTprocessivity, reduced nucleotide-dependent primer unblocking, increased fidelity,...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.